67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Koreanischen Gesellschaft für Neurochirurgie (KNS)
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
12. - 15. Juni 2016, Frankfurt am Main
Vorträge Montag, 13. Juni 2016
MO.10 Neuroonkologie 2: Experimentelle Neuroonkologie
Meeting Abstract
(MO.10.02)
[Volltext]
Frequency of BRAF V600E mutations in 1,031 central nervous system neoplasms – a retrospective single center analysis
Behling F, Barrantes-Freer A, Tatagiba M, Hartmann C, Stadelmann C, Schittenhelm J[Volltext]
Meeting Abstract
(MO.10.03)
[Volltext]
Different methylation pattern in pilocytic astrocytoma
Sippl C, Urbschat S, Kim JY, Oertel J, Ketter R[Volltext]
Meeting Abstract
(MO.10.04)
[Volltext]
Assessment of molecular markers reveals homogeneity between stereotactic and open surgical sample acquisition in anaplastic astrocytomas and glioblastomas
Geßler F, Baumgarten P, Bruder M, Seifert V, Marquardt G, Weise L[Volltext]
Meeting Abstract
(MO.10.05)
[Volltext]
Perioperative administration of corticosteroids in patients with primary CNS B-Cell-Lymphoma
Geßler F, Baumgarten P, Quick J, Marquardt G, Seifert V, Weise L[Volltext]
Meeting Abstract
(MO.10.06)
[Volltext]
Gender-specific growth dynamics of neurofibromatosis-type-2-related tumors of the central nervous system
Lawson McLean A, Rosahl S[Volltext]
Meeting Abstract
(MO.10.07)
[Volltext]
TERT promotor mutational status – an independent prognostic factor in IDH wildtype WHO grade II gliomas
Oehlschlägel F, Schüller U, Biczok A, Tonn JC, Kreth FW, Kreth S[Volltext]
Meeting Abstract
(MO.10.08)
[Volltext]
Immune phenotype of glioblastoma patients and properties of established cell lines
Mostafa H, Dietrich E, Pala A, Wirtz CR, Schneider EM[Volltext]
Meeting Abstract
(MO.10.09)
[Volltext]
The role of extent of resection in the management of IDH-mutant glioma patients
Juratli TA, Zolal A, Riedl A, Thiede C, Krex D, Schackert G[Volltext]
